Mettler Toledo (MTD) Q2 2025 10-Q Quarterly Report

Filed: Aug 1, 2025Period ending Jun 30, 2025
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 1, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Mettler Toledo Q2 2025 10-Q Analysis

Risk Factors

  • New tax legislation in U.S. enacted July 4, 2025; company evaluating impact, expects no significant effect on projected tax rate
  • Increased tariff costs significantly reduced gross profit margins, partially offset by price realization and cost savings initiatives in Q2 2025
  • Compliance risk from inflation reduction act excise taxes totaling $4.1 million in six months ended June 2025, reflected as shareholders' equity reduction
  • Shipping delays recovery during 2024 reduced six-month 2025 sales growth by 1-6% across regions, impacting near-term revenue trends
  • Foreign exchange risk: 5% U.S. dollar weakening would increase reported debt by approx. $54.8 million due to multi-currency borrowings

Mettler Toledo Q2 2025 Quarterly Financials
XBRL

Revenue

$983M

+11.3% QoQ

Net Income

$202M

+23.7% QoQ

Net Margin

20.6%

+207bp QoQ

Source: XBRL data from Mettler Toledo Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Mettler Toledo Quarterly Reports

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.